Inventor · disambiguated record
Massimo Iacobelli
Also filed as: IACOBELLI MASSIMO
8 granted patents·11 pending applications·310 citations·filing 2002–2022
88Inventor score
Top patents by PatentIndex Score
19 records- 0196US6827351B2Link mechanism of surgical robotNUOVO PIGNONE SPA·Filed 2002·Granted Dec 7, 2004·252 cites·17 claims
- 0293US9539277B2Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (GVHD)GENTIUM SPA·Filed 2015·Granted Jan 10, 2017·9 cites·14 claims
- 0392US9867843B2Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (GVHD)GENTIUM SPA·Filed 2016·Granted Jan 16, 2018·6 cites·18 claims
- 0491US8551967B2Formulations with anti-tumour actionFERRO LAURA IRIS·Filed 2006·Granted Oct 8, 2013·21 cites·14 claims
- 0589US8980862B2Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD)IACOBELLI MASSIMO·Filed 2010·Granted Mar 17, 2015·10 cites·14 claims
- 0683US9782429B2Formulation having mobilizing activityGENTIUM SPA·Filed 2014·Granted Oct 10, 2017·3 cites·16 claims
- 0782US8771663B2Formulation having mobilising activityFERRO LAURA·Filed 2010·Granted Jul 8, 2014·8 cites·11 claims
- 0871US2021052622A1Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd)GENTIUM S R L·Filed 2020·Application pending·0 cites
- 0970US7662777B2Use of sulglicotide for the treatment of mucositisGENTIUM SPA·Filed 2005·Granted Feb 16, 2010·1 cites·6 claims
- 1065US2023084937A1Methods for treating patients having sinusoidal obstruction syndromeGENTIUM S R L·Filed 2022·Application pending·0 cites
- 1164US2017304349A1Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd)GENTIUM S R L·Filed 2017·Application pending·0 cites
- 1261US2019328765A1Methods for treating patients having sinusoidal obstruction syndromeGENTIUM S R L·Filed 2019·Application pending·0 cites
- 1360US2008194506A1Oligodeoxyribonuleotides of 4000-10000 Dalton for TreatingGENTIUM SPA·Filed 2006·Application pending·0 cites
- 1460US2011092576A1Synthetic phosphodiester oligonucleotides and therapeutical uses thereofGENTIUM SPA·Filed 2009·Application pending·0 cites
- 1559US2014005256A1Formulations with anti-tumour actionGENTIUM SPA·Filed 2013·Application pending·0 cites
- 1657US2008194507A1Defibrotide An/Or Oligodeoxyribonucleotides For Treating Angiogenesis-Dependent TumorsIACOBELLI MASSIMO·Filed 2006·Application pending·0 cites
- 1753US2009131362A1Use of defibrotide for the inhibition of heparanaseGENTIUM SPA·Filed 2007·Application pending·0 cites
- 1847US2010298413A1Use of oligotide for the treatment of renal diseasesGENTIUM SPA·Filed 2008·Application pending·0 cites
- 1939US2015196580A1Use of defibrotide for the inhibition of heparanaseGENTIUM SPA·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →